Form 10-Q |
ý | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
HEALTHEQUITY, INC. | ||
Delaware | 7389 | 52-2383166 | ||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
Large accelerated filer | þ | Accelerated filer | ¨ |
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Page | ||
Part I. FINANCIAL INFORMATION | ||
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Part II. OTHER INFORMATION | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 6. | ||
(in thousands, except par value) | April 30, 2017 | January 31, 2017 | |||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 155,085 | $ | 139,954 | |||
Marketable securities, at fair value | 40,472 | 40,405 | |||||
Total cash, cash equivalents and marketable securities | 195,557 | 180,359 | |||||
Accounts receivable, net of allowance for doubtful accounts of $75 as of April 30, 2017 and January 31, 2017 | 18,988 | 17,001 | |||||
Inventories | 529 | 592 | |||||
Other current assets | 4,069 | 2,867 | |||||
Total current assets | 219,143 | 200,819 | |||||
Property and equipment, net | 6,083 | 5,170 | |||||
Intangible assets, net | 64,683 | 65,020 | |||||
Goodwill | 4,651 | 4,651 | |||||
Deferred tax asset | 6,438 | 1,615 | |||||
Other assets | 1,851 | 1,861 | |||||
Total assets | $ | 302,849 | $ | 279,136 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 1,545 | $ | 3,221 | |||
Accrued compensation | 4,325 | 8,722 | |||||
Accrued liabilities | 4,435 | 3,760 | |||||
Total current liabilities | 10,305 | 15,703 | |||||
Long-term liabilities | |||||||
Other long-term liabilities | 1,700 | 1,456 | |||||
Deferred tax liability | — | 37 | |||||
Total long-term liabilities | 1,700 | 1,493 | |||||
Total liabilities | 12,005 | 17,196 | |||||
Commitments and contingencies (see note 6) | |||||||
Stockholders’ equity | |||||||
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of April 30, 2017 and January 31, 2017, respectively | — | — | |||||
Common stock, $0.0001 par value, 900,000 shares authorized, 59,904 and 59,538 shares issued and outstanding as of April 30, 2017 and January 31, 2017, respectively | 6 | 6 | |||||
Additional paid-in capital | 238,953 | 232,114 | |||||
Accumulated other comprehensive loss | (191 | ) | (165 | ) | |||
Accumulated earnings | 52,076 | 29,985 | |||||
Total stockholders’ equity | 290,844 | 261,940 | |||||
Total liabilities and stockholders’ equity | $ | 302,849 | $ | 279,136 |
(in thousands, except per share data) | Three months ended April 30, | ||||||
2017 | 2016 | ||||||
Revenue: | |||||||
Service revenue | $ | 22,487 | $ | 18,994 | |||
Custodial revenue | 19,319 | 13,811 | |||||
Interchange revenue | 13,615 | 11,208 | |||||
Total revenue | 55,421 | 44,013 | |||||
Cost of revenue: | |||||||
Service costs | 15,575 | 11,257 | |||||
Custodial costs | 2,801 | 2,356 | |||||
Interchange costs | 3,304 | 2,719 | |||||
Total cost of revenue | 21,680 | 16,332 | |||||
Gross profit | 33,741 | 27,681 | |||||
Operating expenses: | |||||||
Sales and marketing | 4,621 | 4,183 | |||||
Technology and development | 6,242 | 4,625 | |||||
General and administrative | 5,868 | 4,574 | |||||
Amortization of acquired intangible assets | 1,083 | 1,049 | |||||
Total operating expenses | 17,814 | 14,431 | |||||
Income from operations | 15,927 | 13,250 | |||||
Other expense: | |||||||
Other expense, net | (90 | ) | (641 | ) | |||
Total other expense | (90 | ) | (641 | ) | |||
Income before income taxes | 15,837 | 12,609 | |||||
Income tax provision | 1,808 | 4,536 | |||||
Net income | $ | 14,029 | $ | 8,073 | |||
Net income per share: | |||||||
Basic | $ | 0.23 | $ | 0.14 | |||
Diluted | $ | 0.23 | $ | 0.14 | |||
Weighted-average number of shares used in computing net income per share: | |||||||
Basic | 59,720 | 57,820 | |||||
Diluted | 61,400 | 59,399 | |||||
Comprehensive income: | |||||||
Net income | $ | 14,029 | $ | 8,073 | |||
Other comprehensive loss: | |||||||
Unrealized loss on available-for-sale marketable securities, net of tax | (26 | ) | (39 | ) | |||
Comprehensive income | $ | 14,003 | $ | 8,034 |
Three months ended April 30, | |||||||
(in thousands) | 2017 | 2016 | |||||
Cash flows from operating activities: | |||||||
Net income | $ | 14,029 | $ | 8,073 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 3,482 | 2,947 | |||||
Amortization of deferred financing costs and other | 41 | 18 | |||||
Deferred taxes | 3,218 | 34 | |||||
Stock-based compensation | 3,010 | 1,822 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (1,987 | ) | (1,398 | ) | |||
Inventories | 63 | 22 | |||||
Other assets | (1,207 | ) | (4,739 | ) | |||
Accounts payable | (1,545 | ) | (1,241 | ) | |||
Accrued compensation | (4,397 | ) | (5,173 | ) | |||
Accrued liabilities | 625 | 1,164 | |||||
Other long-term liabilities | 244 | 583 | |||||
Net cash provided by operating activities | 15,576 | 2,112 | |||||
Cash flows from investing activities: | |||||||
Purchases of marketable securities | (109 | ) | (86 | ) | |||
Purchase of property and equipment | (1,437 | ) | (321 | ) | |||
Purchase of software and capitalized software development costs | (2,728 | ) | (2,003 | ) | |||
Net cash used in investing activities | (4,274 | ) | (2,410 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from exercise of common stock options | 3,829 | 145 | |||||
Tax benefit from exercise of common stock options | — | 9,278 | |||||
Net cash provided by financing activities | 3,829 | 9,423 | |||||
Increase in cash and cash equivalents | 15,131 | 9,125 | |||||
Beginning cash and cash equivalents | 139,954 | 83,641 | |||||
Ending cash and cash equivalents | $ | 155,085 | $ | 92,766 | |||
Supplemental disclosures of non-cash investing and financing activities: | |||||||
Purchases of property and equipment included in accounts payable or accrued liabilities at period end | $ | 133 | $ | 8 | |||
Purchases of software and capitalized software development costs included in accounts payable or accrued liabilities at period end | 141 | 111 |
(in thousands, except per share data) | Three months ended April 30, | ||||||
2017 | 2016 | ||||||
Numerator (basic and diluted): | |||||||
Net income | $ | 14,029 | $ | 8,073 | |||
Denominator (basic): | |||||||
Weighted-average common shares outstanding | 59,720 | 57,820 | |||||
Denominator (diluted): | |||||||
Weighted-average common shares outstanding | 59,720 | 57,820 | |||||
Weighted-average dilutive effect of stock options and restricted stock units | 1,680 | 1,579 | |||||
Diluted weighted-average common shares outstanding | 61,400 | 59,399 | |||||
Net income per share: | |||||||
Basic | $ | 0.23 | $ | 0.14 | |||
Diluted | $ | 0.23 | $ | 0.14 |
(in thousands) | Cost basis | Gross unrealized gains | Gross unrealized losses | Fair value | |||||||||||
Cash and cash equivalents | $ | 155,085 | $ | — | $ | — | $ | 155,085 | |||||||
Marketable securities: | |||||||||||||||
Mutual funds | 40,779 | 232 | (539 | ) | 40,472 | ||||||||||
Total cash, cash equivalents and marketable securities | $ | 195,864 | $ | 232 | $ | (539 | ) | $ | 195,557 |
(in thousands) | Cost basis | Gross unrealized gains | Gross unrealized losses | Fair value | |||||||||||
Cash and cash equivalents | $ | 139,954 | $ | — | $ | — | $ | 139,954 | |||||||
Marketable securities: | |||||||||||||||
Mutual funds | 40,670 | 207 | (472 | ) | 40,405 | ||||||||||
Total cash, cash equivalents and marketable securities | $ | 180,624 | $ | 207 | $ | (472 | ) | $ | 180,359 |
(in thousands) | Cost basis | Fair value | |||||
One year or less | $ | 25,420 | $ | 25,362 | |||
Over one year and less than five years | 15,359 | 15,110 | |||||
Total | $ | 40,779 | $ | 40,472 |
Less than one year | Greater than one year | ||||||||||||||
(in thousands) | Fair value | Unrealized losses | Fair value | Unrealized losses | |||||||||||
Mutual funds | $ | 25,362 | $ | (207 | ) | $ | 15,110 | $ | (332 | ) |
(in thousands) | April 30, 2017 | January 31, 2017 | ||||||
Leasehold improvements | $ | 1,096 | $ | 860 | ||||
Furniture and fixtures | 3,643 | 3,129 | ||||||
Computer equipment | 7,989 | 7,194 | ||||||
Property and equipment, gross | 12,728 | 11,183 | ||||||
Accumulated depreciation | (6,645 | ) | (6,013 | ) | ||||
Property and equipment, net | $ | 6,083 | $ | 5,170 |
(in thousands) | April 30, 2017 | January 31, 2017 | ||||||
Amortized intangible assets: | ||||||||
Capitalized software development costs | $ | 26,096 | $ | 23,925 | ||||
Software | 7,383 | 7,041 | ||||||
Acquired intangible member assets | 64,962 | 64,962 | ||||||
Intangible assets, gross | 98,441 | 95,928 | ||||||
Accumulated amortization | (33,758 | ) | (30,908 | ) | ||||
Intangible assets, net | $ | 64,683 | $ | 65,020 |
Three months ended April 30, | |||||||
(in thousands) | 2017 | 2016 | |||||
Cost of revenue | $ | 491 | $ | 375 | |||
Sales and marketing | 317 | 213 | |||||
Technology and development | 672 | 357 | |||||
General and administrative | 1,530 | 877 | |||||
Total stock-based compensation expense | $ | 3,010 | $ | 1,822 |
Outstanding stock options | |||||||||||||||
(in thousands, except for exercise prices and term) | Number of options | Range of exercise prices | Weighted- average exercise price | Weighted- average contractual term (in years) | Aggregate intrinsic value | ||||||||||
Outstanding as of January 31, 2017 | 4,716 | $0.10 - 44.53 | $ | 18.36 | 7.60 | $ | 131,529 | ||||||||
Granted | 370 | $41.28 - 46.40 | $ | 41.61 | |||||||||||
Exercised | (366 | ) | $0.10 - 33.47 | $ | 10.45 | ||||||||||
Forfeited | (55 | ) | $24.36 - 44.53 | $ | 32.70 | ||||||||||
Outstanding as of April 30, 2017 | 4,665 | $0.10 - 46.40 | $ | 20.65 | 7.73 | $ | 116,002 | ||||||||
Vested and expected to vest as of April 30, 2017 | 4,478 | $ | 20.36 | 7.70 | $ | 112,687 | |||||||||
Exercisable as of April 30, 2017 | 1,626 | $ | 11.94 | 6.54 | $ | 54,616 |
Three months ended April 30, | |||||
2017 | 2016 | ||||
Expected dividend yield | — | % | — | % | |
Expected stock price volatility | 37.90% - 38.01% | 38.29% - 38.37% | |||
Risk-free interest rate | 1.90% - 2.07% | 1.33% - 1.52% | |||
Expected life of options | 5.17 - 6.25 years | 5.17 - 6.25 years |
(in thousands, except weight-average grant date fair value) | RSUs and PRSUs | Weighted-average grant date fair value | |||||
Outstanding as of January 31, 2017 | 10 | $ | 26.93 | ||||
Granted | 326 | 41.61 | |||||
Vested | * | 46.40 | |||||
Forfeitures | — | — | |||||
Outstanding as of April 30, 2017 | 336 | $ | 41.15 |
• | Level 1—quoted prices in active markets for identical assets or liabilities; |
• | Level 2—inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and |
• | Level 3—unobservable inputs based on the Company’s own assumptions. |
April 30, 2017 | ||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | |||||||||
Marketable securities: | ||||||||||||
Mutual funds | $ | 40,472 | $ | — | $ | — |
January 31, 2017 | ||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | |||||||||
Marketable securities: | ||||||||||||
Mutual funds | $ | 40,405 | $ | — | $ | — |
April 30, 2017 | April 30, 2016 | % Change | January 31, 2017 | |||||||||
HSA Members | 2,805,280 | 2,228,041 | 26 | % | 2,746,132 | |||||||
Average HSA Members - Year-to-date | 2,782,779 | 2,211,860 | 26 | % | 2,339,091 | |||||||
Average HSA Members - Quarter-to-date | 2,782,779 | 2,211,860 | 26 | % | 2,519,382 | |||||||
HSA Members with investments | 76,996 | 49,761 | 55 | % | 65,906 |
(in thousands, except percentages) | April 30, 2017 | April 30, 2016 | % Change | January 31, 2017 | |||||||||||
Custodial cash | $ | 4,454,928 | $ | 3,597,111 | 24 | % | $ | 4,380,487 | |||||||
Custodial investments | 772,867 | 488,343 | 58 | % | 658,580 | ||||||||||
Total custodial assets | $ | 5,227,795 | $ | 4,085,454 | 28 | % | $ | 5,039,067 | |||||||
Average daily custodial cash - Year-to-date | $ | 4,410,507 | $ | 3,518,081 | 25 | % | $ | 3,661,058 | |||||||
Average daily custodial cash - Quarter-to-date | $ | 4,410,507 | $ | 3,518,081 | 25 | % | $ | 3,854,518 |
Three months ended April 30, | |||||||
(in thousands) | 2017 | 2016 | |||||
Net income | $ | 14,029 | $ | 8,073 | |||
Interest income | (157 | ) | (120 | ) | |||
Interest expense | 67 | 68 | |||||
Income tax provision | 1,808 | 4,536 | |||||
Depreciation and amortization | 2,398 | 1,898 | |||||
Amortization of acquired intangible assets | 1,083 | 1,049 | |||||
Stock-based compensation expense | 3,010 | 1,822 | |||||
Other (1) | 180 | 693 | |||||
Adjusted EBITDA | $ | 22,418 | $ | 18,019 |
(1) | For the three months ended April 30, 2017 and 2016, Other consisted of non-income-based taxes of $88 and $84, other costs of $54 and $24, and acquisition-related costs of $38 and $585, respectively. |
Three months ended April 30, | |||||||||||
(in thousands, except percentages) | 2017 | 2016 | $ Change | % Change | |||||||
Adjusted EBITDA | $ | 22,418 | $ | 18,019 | $ | 4,399 | 24 | % | |||
As a percentage of revenue | 40 | % | 41 | % |
Three months ended April 30, | ||||||||||||||
(in thousands, except percentages) | 2017 | 2016 | $ Change | % Change | ||||||||||
Service revenue | $ | 22,487 | $ | 18,994 | $ | 3,493 | 18 | % | ||||||
Custodial revenue | 19,319 | 13,811 | 5,508 | 40 | % | |||||||||
Interchange revenue | 13,615 | 11,208 | 2,407 | 21 | % | |||||||||
Total revenue | $ | 55,421 | $ | 44,013 | $ | 11,408 | 26 | % |
(in thousands, except percentages) | Three months ended April 30, | |||||||||||||
2017 | 2016 | $ Change | % Change | |||||||||||
Service costs | $ | 15,575 | $ | 11,257 | $ | 4,318 | 38 | % | ||||||
Custodial costs | 2,801 | 2,356 | 445 | 19 | % | |||||||||
Interchange costs | 3,304 | 2,719 | 585 | 22 | % | |||||||||
Total cost of revenue | $ | 21,680 | $ | 16,332 | $ | 5,348 | 33 | % |
(in thousands, except percentages) | Three months ended April 30, | |||||||||||||
2017 | 2016 | $ Change | % Change | |||||||||||
Sales and marketing | $ | 4,621 | $ | 4,183 | $ | 438 | 10 | % | ||||||
Technology and development | 6,242 | 4,625 | 1,617 | 35 | % | |||||||||
General and administrative | 5,868 | 4,574 | 1,294 | 28 | % | |||||||||
Amortization of acquired intangible assets | 1,083 | 1,049 | 34 | 3 | % | |||||||||
Total operating expenses | $ | 17,814 | $ | 14,431 | $ | 3,383 | 23 | % |
Three months ended April 30, | ||||||||
(in thousands) | 2017 | 2016 | ||||||
Net cash provided by operating activities | $ | 15,576 | $ | 2,112 | ||||
Net cash used in investing activities | (4,274 | ) | (2,410 | ) | ||||
Net cash provided by financing activities | 3,829 | 9,423 | ||||||
Increase (decrease) in cash and cash equivalents | 15,131 | 9,125 | ||||||
Beginning cash and cash equivalents | 139,954 | 83,641 | ||||||
Ending cash and cash equivalents | $ | 155,085 | $ | 92,766 |
HEALTHEQUITY, INC. | |||
Date: June 8, 2017 | By: | /s/ Darcy Mott | |
Name: | Darcy Mott | ||
Title: | Executive Vice President and Chief Financial Officer |
Incorporate by reference | ||||||
Exhibit no. | Description | Form | File No. | Exhibit | Filing Date | |
10.1+ | First Amendment to Amended and Restated Lease Agreement, dated June 1, 2016, by and between the Company and the Landlord. | |||||
10.2+ | Second Amendment to Amended and Restated Lease Agreement, dated May 31, 2017, by and between the Company and the Landlord. | |||||
21.1+ | List of Subsidiaries. | |||||
31.1+ | Certification of the Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
31.2+ | Certification of the Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
32.1*# | Certification of the Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
32.2*# | Certification of the Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
101.INS†† | XBRL Instance document | |||||
101.SCH†† | XBRL Taxonomy schema linkbase document | |||||
101.CAL†† | XBRL Taxonomy calculation linkbase document | |||||
101.DEF†† | XBRL Taxonomy definition linkbase document | |||||
101.LAB†† | XBRL Taxonomy labels linkbase document | |||||
101.PRE†† | XBRL Taxonomy presentation linkbase document |
+ | Filed herewith | |
* | Furnished herewith | |
# | These certifications are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference in any filing the registrant makes under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, irrespective of any general incorporation language in any filings. | |
†† | In accordance with Rule 406T of Regulation S-T, the information in these exhibits is furnished and deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Exchange Act of 1934, and otherwise is not subject to liability under these sections. |
LANDLORD: | BG SCENIC POINT OFFICE 1 L.C., a Utah limited liability company, by its manager |
By: | _______________________ Name: Title: Manager |
TENANT: | HEALTHEQUITY, INC., a Delaware corporation |
January 1, 2018 – December 31, 2018 | $18.36 per rentable square foot |
January 1, 2019 – December 31, 2019 | $18.93 per rentable square foot |
January 1, 2020 – April 30, 2020 | $19.49 per rentable square foot |
May 1, 2020 – April 30, 2021 | $20.00 per rentable square foot |
May 1, 2021 – April 30, 2022 | $20.50 per rentable square foot |
May 1, 2022 – April 30, 2023 | $21.01 per rentable square foot |
May 1, 2023 – April 30, 2024 | $21.54 per rentable square foot |
May 1, 2024 – April 30, 2025 | $22.07 per rentable square foot |
May 1, 2025 – April 30, 2026 | $22.63 per rentable square foot |
May 1, 2026 – March 31, 2027 | $23.19 per rentable square foot |
LANDLORD: | BG SCENIC POINT OFFICE 1 L.C., a Utah limited liability company, by its manager |
By: | _______________________ Name: Title: Manager |
TENANT: | HEALTHEQUITY, INC., a Delaware corporation |
1. | I have reviewed this Quarterly Report on Form 10-Q of HealthEquity, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
By: | /s/ Jon Kessler | |
Name: | Jon Kessler | |
Title: | Chief Executive Officer (Principal Executive Officer) |
1. | I have reviewed this Quarterly Report on Form 10-Q of HealthEquity, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
By: | /s/ Darcy Mott | |
Name: | Darcy Mott | |
Title: | Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
1. | Our Quarterly Report on Form 10-Q for the quarter ended April 30, 2017 (the “Report”), of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: | /s/ Jon Kessler | |
Name: | Jon Kessler | |
Title: | Chief Executive Officer (Principal Executive Officer) |
1. | Our Quarterly Report on Form 10-Q for the quarter ended April 30, 2017 (the “Report”), of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: | /s/ Darcy Mott | |
Name: | Darcy Mott | |
Title: | Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
May 31, 2017 |
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | HEALTHEQUITY INC | |
Entity Central Index Key | 0001428336 | |
Current Fiscal Year End Date | --01-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Apr. 30, 2017 | |
Document Fiscal Year Focus | 2018 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 59,973,713 |
Condensed consolidated balance sheets (unaudited) (Parenthetical) - USD ($) $ in Thousands |
Apr. 30, 2017 |
Jan. 31, 2017 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 75 | $ 75 |
Preferred Stock, Par Value (usd per share) | $ 0.0001 | $ 0.0001 |
Preferred Stock, Shares Authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred Stock, Shares Issued (in shares) | 0 | 0 |
Preferred Stock, Shares Outstanding (in shares) | 0 | 0 |
Common Stock, Par Value (usd per share) | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized (in shares) | 900,000,000 | 900,000,000 |
Common Stock, Shares, Issued (in shares) | 59,904,000 | 59,538,000 |
Common Stock, Shares, Outstanding (in shares) | 59,904,000 | 59,538,000 |
Summary of business and significant accounting policies |
3 Months Ended |
---|---|
Apr. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Summary of business and significant accounting policies | HealthEquity, Inc. was incorporated in the state of Delaware on September 18, 2002. The Company offers a full range of innovative solutions for managing health care accounts (Health Savings Accounts, Health Reimbursement Arrangements, and Flexible Spending Accounts) for health plans, insurance companies, and third-party administrators. Principles of consolidation—The condensed consolidated financial statements include the accounts of HealthEquity, Inc. and its wholly owned subsidiaries, HealthEquity Trust Company, HEQ Insurance Services, Inc., HealthEquity Advisors, LLC and HealthEquity Retirement Services, LLC (collectively referred to as, the "Company"). The Company has a 22% ownership interest in a limited partnership for investment in and the management of early stage companies in the healthcare industry, such partnership is accounted for using the equity method of accounting. The investment was approximately $206,000 as of April 30, 2017 and is included in other assets on the accompanying condensed consolidated balance sheet. The Company has a 2% ownership interest in a limited partnership that engages in the development of technology-based financial healthcare products. The Company determined there was no significant influence and therefore the investment was accounted for using the cost method of accounting. The investment was $500,000 as of April 30, 2017 and is included in other assets on the accompanying condensed consolidated balance sheet. All significant intercompany balances and transactions have been eliminated. Basis of presentation—The accompanying condensed consolidated financial statements as of April 30, 2017 and for the three months ended April 30, 2017 and 2016 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended January 31, 2017. The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. Recent adopted accounting pronouncements—In March 2016, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2016-09, Improvements to Employee Share-Based Payment Accounting. This ASU requires excess tax benefits and tax deficiencies to be recognized in the statement of operations and comprehensive income, which were previously presented as a component of stockholders' equity, on a prospective basis. In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective bases through a cumulative-effect adjustment to retained earnings. This ASU also requires cash flows related to excess tax benefits to be classified an an operating activity on the statement of cash flows. Finally, this ASU no longer allows tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted weighted-average common shares outstanding, which results in share-based awards having a more dilutive effect on net income per diluted share. The Company adopted this ASU during the three months ended April 30, 2017. As required by the standard, excess tax benefits recognized on stock-based compensation expense are reflected in our condensed consolidated statements of operations and comprehensive income as a component of the provision for income taxes rather than additional paid-in capital on a prospective basis. For the three months ended April 30, 2017, the Company recorded excess tax benefits in the amount of $3.9 million within our provision for income taxes in the condensed consolidated statements of operations and comprehensive income. In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $8.1 million to our retained earnings as of February 1, 2017. For presentation requirements, the Company elected to prospectively apply the change in the presentation of excess tax benefits wherein excess tax benefits recognized on stock-based compensation expense are classified as operating activities on the condensed consolidated statements of cash flows for the three months ended April 30, 2017. Prior period classification of cash flows related to excess tax benefits were not adjusted. Further, the Company did not elect to adopt the forfeiture provisions of this ASU. Recent issued accounting pronouncements—On May 28, 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. In July 2015, the FASB voted to defer the effective date to fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption beginning for fiscal years, and interim periods within those fiscal years, beginning after December 31, 2016. The standard permits the use of either the retrospective or cumulative effect transition method. In March 2016, the FASB issued ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in determining revenue recognition as principal versus agent. In April 2016, the FASB issued ASU 2016-10, Identifying Performance Obligations and Licensing, which provides guidance in accounting for immaterial performance obligations and shipping and handling. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, which provides clarification on assessing the collectability criterion, presentation of sales taxes, measurement date for noncash consideration and completed contracts at transition. Finally, in December 2016, the FASB issued ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers, which makes minor corrections or minor improvements to the Codification that are not expected to have a significant impact. The foregoing amendments are effective for annual reporting periods beginning after December 15, 2017 and for interim reporting periods within such annual periods. The adoption of this guidance is not expected to have a material impact on the Company's revenue. The Company is still evaluating the impact of this guidance on sales commissions. The Company will use the cumulative effect transition method and does not plan to early adopt. In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Liabilities. The amendments in this ASU revise an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. This ASU also amends certain disclosure requirements associated with the fair value of financial instruments. The amendments in this ASU are effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted for the presentation of certain fair value changes for financial liabilities measured at fair value. The Company does not plan to early adopt and is currently evaluating the potential effect of this ASU on the consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure for both parties to a contract (i.e. lessees and lessors). ASC 842 supersedes the previous leases standard, ASC 840 leases. This ASU is effective for financial statements issued for reporting periods beginning after December 15, 2018 and requires a modified retrospective transition, and provides for certain practical expedients; early adoption is permitted. The Company does not plan to early adopt and is currently evaluating the potential effect of this ASU on the consolidated financial statements. In June 2016, The FASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The Company does not plan to early adopt this ASU. The Company believes the adoption of this ASU will have an immaterial impact on its consolidated financial statements. In August 2016, The FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), which provides guidance on the classification of certain cash receipts and cash payments. This ASU is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company does not plan to early adopt this ASU. The Company believes the adoption of this ASU will have an immaterial impact on its consolidated financial statements. In October 2016, The FASB issued ASU 2016-16, Income Taxes (Topic 740) - Intra-Entity Transfers of Assets Other Than Inventory, which updates the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. This ASU is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adoption and the potential effect of this ASU on the consolidated financial statements. In January 2017, The FASB issued ASU 2017-01, Business Combinations: Clarifying the Definition of a Business, which provides a more robust framework to use in determining when a set of assets and activities is a business. This ASU is effective for fiscal years beginning December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The new guidance is required to be applied on a prospective basis. The Company is currently evaluating the timing of adoption. The effect of the implementation will depend upon the nature of the Company's future acquisitions, if any. In January 2017, The FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes step two from the goodwill impairment test. As a result, an entity should perform its annual goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount and should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting units' fair value. This ASU is effective for fiscal years beginning December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adoption; however it does not believe this ASU will have material impact on the Company's consolidated financial statements. |
Net income per share |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income per share | The following table sets forth the computation of basic and diluted net income per share:
For the three months ended April 30, 2017 and 2016, approximately 583,000 and 1.6 million shares, respectively, attributable to stock options were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive. |
Cash, cash equivalents and marketable securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash, cash equivalents and marketable securities | Cash, cash equivalents and marketable securities as of April 30, 2017 consisted of the following:
Cash, cash equivalents and marketable securities as of January 31, 2017 consisted of the following:
The following table summarizes the cost basis and fair value of the marketable securities by contractual maturity as of April 30, 2017:
Unrealized losses from marketable securities are primarily attributable to change in interest rates. The Company does not believe any remaining unrealized losses represent other-than-temporary impairments based on the Company's evaluation of available evidence as of April 30, 2017. As of April 30, 2017, marketable securities with an unrealized loss position for more than twelve consecutive months were as follows:
|
Property and equipment |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property and equipment | Property and equipment consisted of the following as of April 30, 2017 and January 31, 2017:
Depreciation expense for the three months ended April 30, 2017 and 2016 was $632,000 and $447,000, respectively. |
Intangible assets and goodwill |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible assets and goodwill | During the three months ended April 30, 2017 and 2016, the Company capitalized software development costs of $2.2 million and $1.9 million, respectively, related to significant enhancements and upgrades to its proprietary system. The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of April 30, 2017 and January 31, 2017:
During the three months ended April 30, 2017 and 2016, the Company incurred and expensed a total of $2.8 million and $2.1 million, respectively, in software development costs primarily related to the post-implementation and operation stages of its proprietary software. Amortization expense for the three months ended April 30, 2017 and 2016 was $2.8 million and $2.5 million, respectively. There were no changes to the goodwill carrying value during the three months ended April 30, 2017 and 2016. |
Commitment and contingencies |
3 Months Ended |
---|---|
Apr. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and contingencies | The Company’s principal commitments and contingencies consist of a processing services agreement with a vendor, and obligations for office space, telephony services, data storage facilities, equipment and certain maintenance agreements under long-term, non-cancelable operating leases. These commitments as of January 31, 2017 are disclosed in the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the year ended January 31, 2017, and did not change materially during the three months ended April 30, 2017. Lease expense for office space for the three months ended April 30, 2017 and 2016 was $1.1 million, and $593,000, respectively. Expense for other lease agreements for the three months ended April 30, 2017 and 2016 was $120,000 and $60,000, respectively. |
Indebtedness |
3 Months Ended |
---|---|
Apr. 30, 2017 | |
Debt Disclosure [Abstract] | |
Indebtedness | On September 30, 2015, the Company entered into a new credit facility (the "Credit Agreement"). The Credit Agreement provides for a secured revolving credit facility in the aggregate principal amount of $100.0 million for a term of five years. The proceeds of borrowings under the Credit Agreement may be used for general corporate purposes. No amounts have been drawn under the Credit Agreement as of April 30, 2017. Borrowings under the Credit Agreement bear interest equal to, at the Company's option, a) an adjusted LIBOR rate or b) a customary base rate, in each case with an applicable spread to be determined based on the Company's leverage ratio as of the most recent fiscal quarter. The applicable spread for borrowing under the Credit Agreement ranges from 1.50% to 2.00% with respect to adjusted LIBOR rate borrowings and 0.50% to 1.00% with respect to customary base rate borrowings. Additionally, the Company pays a commitment fee ranging from 0.20% to 0.30% on the daily amount of the unused commitments under the Credit Agreement payable in arrears at the end of each fiscal quarter. The Company's material subsidiaries are required to guarantee the obligations of the Company under the Credit Agreement. The obligations of the Company and the guarantors under the Credit Agreement and the guarantees are secured by substantially all assets of the Company and the guarantors, subject to customary exclusions and exceptions. The Credit Agreement requires the Company to maintain a total leverage ratio of not more than 3.00 to 1.00 as of the end of each fiscal quarter and a minimum interest coverage ratio of at least 3.00 to 1.00 as of the end of each fiscal quarter. In addition, the Credit Agreement includes customary representations and warranties, affirmative and negative covenants, and events of default. The restrictive covenants include customary restrictions on the Company's ability to incur additional indebtedness; make investments, loans or advances; grant or incur liens on assets; engage in mergers, consolidations, liquidations or dissolutions; engage in transactions with affiliates; and make dividend payments. The Company was in compliance with these covenants as of April 30, 2017. |
Income taxes |
3 Months Ended |
---|---|
Apr. 30, 2017 | |
Income Tax Disclosure [Abstract] | |
Income taxes | The Company follows FASB Accounting Standards Codification 740-270, Income Taxes - Interim Reporting, for the computation and presentation of its interim period tax provision. Accordingly, management estimated the effective annual tax rate and applied this rate to the year-to-date pre-tax book income to determine the interim provision for income taxes. For the three months ended April 30, 2017, the Company recorded a provision for income taxes of $1.8 million. The resulting effective income tax rate was 11.4%, compared with an effective income tax rate of 36.0% for the three months ended April 30, 2016. For the three months ended April 30, 2017, the net impact of discrete tax items caused a 24.8 percentage point decrease to the effective income tax rate primarily due to the excess tax benefit on stock-based compensation expense recognized in the provision for income taxes on the condensed consolidated statements of income, pursuant to the adoption of ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. For the three months ended April 30, 2016, the net impact of discrete tax items was not material. The decrease in the effective income tax rate from the same period last year is primarily due to the excess tax benefit on stock-based compensation expense recognized in the provision for income taxes on the condensed consolidated statements of income during the three months ended April 30, 2017, pursuant to the adoption of ASU 2016-09. As of April 30, 2017 and January 31, 2017, the Company’s total gross unrecognized tax benefit was $741,000 and $674,000, respectively. As a result of ASU No. 2013-11, certain unrecognized tax benefits have been netted against their related deferred tax assets; therefore, no unrecognized tax benefit has been recorded as of April 30, 2017 and January 31, 2017. If recognized, $622,000 of the total gross unrecognized tax benefits would affect the Company's effective income tax rate as of April 30, 2017. The Company files income tax returns with U.S. federal and state taxing jurisdictions and is not currently under examination with any jurisdiction. The Company remains subject to examination by federal and various state taxing jurisdictions for tax years after 2005. |
Stock-based compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income during the periods presented:
Stock options Stock option activity under the Company's equity incentive plans is as follows:
The aggregate intrinsic value in the table above represents the difference between the estimated fair value of common stock and the exercise price of outstanding, in-the-money stock options. The key input assumptions that were utilized in the valuation of the stock options granted during the periods presented:
The determination of the fair value of stock options on the date of grant using an option pricing model is affected by the Company's stock price as well as assumptions regarding a number of complex and subjective variables. Expected volatility is determined using weighted average volatility of publicly traded peer companies. The Company expects that it will begin using its own historical volatility in addition to the volatility of publicly traded peer companies, as its share price history grows over time. The risk-free interest rate is determined by using published zero coupon rates on treasury notes for each grant date given the expected term on the options. The dividend yield of zero is based on the fact that the Company expects to invest cash in operations. The Company uses the "simplified" method to estimate expected term as determined under Staff Accounting Bulletin No. 110 due to the lack of sufficient option exercise history as a public company. As of April 30, 2017, the weighted-average vesting period of non-vested awards expected to vest is approximately 2.4 years; the amount of compensation expense the Company expects to recognize for stock options vesting in future periods is approximately $23.2 million. Restricted stock units The Company grants restricted stock units ("RSU") to certain team members, officers, and directors under the 2014 Equity Incentive Plan. RSUs vest upon service-based criteria and performance-based criteria. Generally, service-based restricted stock units vest over a four-year period in equal annual installments commencing upon the first anniversary of the grant date. Performance-based restricted stock units ("PRSU") vest upon the achievement of certain financial criteria and cliff vest on January 31, 2020. RSUs are valued based on the current value of the Company's closing stock price on the date of grant and stock-based compensation expense is recognized over the requisite service period. Stock-based compensation expense for PRSUs is recognized over the requisite service period based on the probable outcome of the achievement of the performance criteria. A summary of the RSU activity is as follows:
* Represents less than 1,000 of vested RSUs. Stock-based compensation expense related to RSUs was $545,000 for the three months ended April 30, 2017. Total unrecorded stock-based compensation expense as of April 30, 2017 associated with RSUs was $11.6 million, which is expected to be recognized over a weighted-average period of 3.3 years. |
Fair value |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value | Fair value measurements are made at a specific point in time, based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair value hierarchy:
Level 1 instruments are valued based on publicly available daily net asset values. Level 1 instruments consist primarily of highly liquid mutual funds. The following tables summarize the assets measured at fair value on a recurring basis and indicates the level within the fair value hierarchy reflecting the valuation techniques utilized to determine fair value:
The carrying value of financial instruments including cash and cash equivalents and certain non-trade receivables approximate fair values as of April 30, 2017 due to the short-term nature of these instruments. The Company has classified cash and cash equivalents as Level 1 and certain non-trade receivables as Level 2 in the fair value hierarchy. |
Subsequent events |
3 Months Ended |
---|---|
Apr. 30, 2017 | |
Subsequent Events [Abstract] | |
Subsequent events | In May 2017, the Company entered into a definitive asset purchase agreement with BenefitGuard LLC, a 401(k) provider that offers 3(16) plan administrator and 3(21) named fiduciary services for 401(k) employer sponsors for an estimated purchase price range between $1.5 million and $3.0 million. The transaction is subject to customary closing conditions. The transaction is expected to be completed during the three months ended October 31, 2017. On May 31, 2017, the Company entered into an amendment to its lease agreement, dated May 15, 2015, by and between the Company and its landlord to expand its current office space. The term of the lease will commence on January 1, 2018 and will expire on March 31, 2027. The Company will be responsible for payment of taxes and operating expenses for its portion of the building, in addition to an annual base rent in the initial amount of approximately $513,000, with annual increases ranging from 2.5% to 3.1%. |
Summary of business and significant accounting policies (Policies) |
3 Months Ended |
---|---|
Apr. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Principles of consolidation | Principles of consolidation—The condensed consolidated financial statements include the accounts of HealthEquity, Inc. and its wholly owned subsidiaries, HealthEquity Trust Company, HEQ Insurance Services, Inc., HealthEquity Advisors, LLC and HealthEquity Retirement Services, LLC (collectively referred to as, the "Company"). The Company has a 22% ownership interest in a limited partnership for investment in and the management of early stage companies in the healthcare industry, such partnership is accounted for using the equity method of accounting. The investment was approximately $206,000 as of April 30, 2017 and is included in other assets on the accompanying condensed consolidated balance sheet. The Company has a 2% ownership interest in a limited partnership that engages in the development of technology-based financial healthcare products. The Company determined there was no significant influence and therefore the investment was accounted for using the cost method of accounting. The investment was $500,000 as of April 30, 2017 and is included in other assets on the accompanying condensed consolidated balance sheet. All significant intercompany balances and transactions have been eliminated. |
Basis of presentation | Basis of presentation—The accompanying condensed consolidated financial statements as of April 30, 2017 and for the three months ended April 30, 2017 and 2016 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended January 31, 2017. The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. |
Recent accounting pronouncements | Recent adopted accounting pronouncements—In March 2016, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2016-09, Improvements to Employee Share-Based Payment Accounting. This ASU requires excess tax benefits and tax deficiencies to be recognized in the statement of operations and comprehensive income, which were previously presented as a component of stockholders' equity, on a prospective basis. In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective bases through a cumulative-effect adjustment to retained earnings. This ASU also requires cash flows related to excess tax benefits to be classified an an operating activity on the statement of cash flows. Finally, this ASU no longer allows tax benefits to be included in the assumed proceeds when applying the treasury stock method for computing diluted weighted-average common shares outstanding, which results in share-based awards having a more dilutive effect on net income per diluted share. The Company adopted this ASU during the three months ended April 30, 2017. As required by the standard, excess tax benefits recognized on stock-based compensation expense are reflected in our condensed consolidated statements of operations and comprehensive income as a component of the provision for income taxes rather than additional paid-in capital on a prospective basis. For the three months ended April 30, 2017, the Company recorded excess tax benefits in the amount of $3.9 million within our provision for income taxes in the condensed consolidated statements of operations and comprehensive income. In addition, any excess tax benefits that were not previously recognized because the related tax deduction had not reduced current taxes payable are to be recorded on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, which resulted in an increase of $8.1 million to our retained earnings as of February 1, 2017. For presentation requirements, the Company elected to prospectively apply the change in the presentation of excess tax benefits wherein excess tax benefits recognized on stock-based compensation expense are classified as operating activities on the condensed consolidated statements of cash flows for the three months ended April 30, 2017. Prior period classification of cash flows related to excess tax benefits were not adjusted. Further, the Company did not elect to adopt the forfeiture provisions of this ASU. Recent issued accounting pronouncements—On May 28, 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. In July 2015, the FASB voted to defer the effective date to fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption beginning for fiscal years, and interim periods within those fiscal years, beginning after December 31, 2016. The standard permits the use of either the retrospective or cumulative effect transition method. In March 2016, the FASB issued ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in determining revenue recognition as principal versus agent. In April 2016, the FASB issued ASU 2016-10, Identifying Performance Obligations and Licensing, which provides guidance in accounting for immaterial performance obligations and shipping and handling. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, which provides clarification on assessing the collectability criterion, presentation of sales taxes, measurement date for noncash consideration and completed contracts at transition. Finally, in December 2016, the FASB issued ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers, which makes minor corrections or minor improvements to the Codification that are not expected to have a significant impact. The foregoing amendments are effective for annual reporting periods beginning after December 15, 2017 and for interim reporting periods within such annual periods. The adoption of this guidance is not expected to have a material impact on the Company's revenue. The Company is still evaluating the impact of this guidance on sales commissions. The Company will use the cumulative effect transition method and does not plan to early adopt. In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Liabilities. The amendments in this ASU revise an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. This ASU also amends certain disclosure requirements associated with the fair value of financial instruments. The amendments in this ASU are effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted for the presentation of certain fair value changes for financial liabilities measured at fair value. The Company does not plan to early adopt and is currently evaluating the potential effect of this ASU on the consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure for both parties to a contract (i.e. lessees and lessors). ASC 842 supersedes the previous leases standard, ASC 840 leases. This ASU is effective for financial statements issued for reporting periods beginning after December 15, 2018 and requires a modified retrospective transition, and provides for certain practical expedients; early adoption is permitted. The Company does not plan to early adopt and is currently evaluating the potential effect of this ASU on the consolidated financial statements. In June 2016, The FASB issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The Company does not plan to early adopt this ASU. The Company believes the adoption of this ASU will have an immaterial impact on its consolidated financial statements. In August 2016, The FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), which provides guidance on the classification of certain cash receipts and cash payments. This ASU is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company does not plan to early adopt this ASU. The Company believes the adoption of this ASU will have an immaterial impact on its consolidated financial statements. In October 2016, The FASB issued ASU 2016-16, Income Taxes (Topic 740) - Intra-Entity Transfers of Assets Other Than Inventory, which updates the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. This ASU is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adoption and the potential effect of this ASU on the consolidated financial statements. In January 2017, The FASB issued ASU 2017-01, Business Combinations: Clarifying the Definition of a Business, which provides a more robust framework to use in determining when a set of assets and activities is a business. This ASU is effective for fiscal years beginning December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The new guidance is required to be applied on a prospective basis. The Company is currently evaluating the timing of adoption. The effect of the implementation will depend upon the nature of the Company's future acquisitions, if any. In January 2017, The FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes step two from the goodwill impairment test. As a result, an entity should perform its annual goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount and should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting units' fair value. This ASU is effective for fiscal years beginning December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adoption; however it does not believe this ASU will have material impact on the Company's consolidated financial statements. |
Net income per share (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of basic and diluted net income per share:
|
Cash, cash equivalents and marketable securities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-sale Securities | Cash, cash equivalents and marketable securities as of April 30, 2017 consisted of the following:
Cash, cash equivalents and marketable securities as of January 31, 2017 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments Classified by Contractual Maturity Date | The following table summarizes the cost basis and fair value of the marketable securities by contractual maturity as of April 30, 2017:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of marketable securities with an unrealized loss position | As of April 30, 2017, marketable securities with an unrealized loss position for more than twelve consecutive months were as follows:
|
Property and equipment (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property and equipment | Property and equipment consisted of the following as of April 30, 2017 and January 31, 2017:
|
Intangible assets and goodwill (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets | The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of April 30, 2017 and January 31, 2017:
|
Stock-based compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of share based compensation recognized | The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income during the periods presented:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of stock option activity | Stock option activity under the Company's equity incentive plans is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Assumptions | The key input assumptions that were utilized in the valuation of the stock options granted during the periods presented:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of restricted stock unit activity | A summary of the RSU activity is as follows:
* Represents less than 1,000 of vested RSUs. |
Fair value (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets Measured at Fair Value on a Recurring Basis | The following tables summarize the assets measured at fair value on a recurring basis and indicates the level within the fair value hierarchy reflecting the valuation techniques utilized to determine fair value:
The carrying value of financial instruments including cash and cash equivalents and certain non-trade receivables approximate fair values as of April 30, 2017 due to the short-term nature of these instruments. The Company has classified cash and cash equivalents as Level 1 and certain non-trade receivables as Level 2 in the fair value hierarchy. |
Summary of business and significant accounting policies (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Jan. 31, 2017 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Ownership percentage | 22.00% | |
Equity method investments | $ 206 | |
Cost method investment, ownership percentage | 2.00% | |
Cost method investments | $ 500 | |
Excess tax benefits related to stock-based compensation | $ 3,900 | |
ASU 2016-09 | Retained Earnings | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Cumulative-effect adjustment to retained earnings for adoption of ASU 2016-09 | $ 8,100 |
Net income per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Earnings Per Share [Abstract] | ||
Net income | $ 14,029 | $ 8,073 |
Denominator (basic): | ||
Weighted-average common shares outstanding (in shares) | 59,720 | 57,820 |
Denominator (diluted): | ||
Weighted-average common shares outstanding (in shares) | 59,720 | 57,820 |
Weighted-average dilutive effect of stock options and restricted stock units (in shares) | 1,680 | 1,579 |
Diluted weighted-average common shares outstanding (in shares) | 61,400 | 59,399 |
Net income per share: | ||
Basic (in dollars per share) | $ 0.23 | $ 0.14 |
Diluted (in dollars per share) | $ 0.23 | $ 0.14 |
Antidilutive securities excluded from computation of earnings per share (in shares) | 583 | 1,600 |
Cash, cash equivalents and marketable securities (Details) - USD ($) $ in Thousands |
Apr. 30, 2017 |
Jan. 31, 2017 |
Apr. 30, 2016 |
Jan. 31, 2016 |
---|---|---|---|---|
Schedule of Available-for-sale Securities [Line Items] | ||||
Cash and cash equivalents, cost basis | $ 155,085 | $ 139,954 | $ 92,766 | $ 83,641 |
Cash and cash equivalents, fair value | 155,085 | 139,954 | ||
Marketable securities: | ||||
Marketable securities, gross unrealized gains | 232 | 207 | ||
Marketable securities, gross unrealized losses | (539) | (472) | ||
Marketable securities, fair value | 40,472 | 40,405 | ||
Total cash, cash equivalents and marketable securities, cost basis | 195,864 | 180,624 | ||
Total cash, cash equivalents and marketable securities, fair value | 195,557 | 180,359 | ||
Mutual funds | ||||
Marketable securities: | ||||
Marketable securities, cost basis | 40,779 | 40,670 | ||
Marketable securities, gross unrealized gains | 232 | 207 | ||
Marketable securities, gross unrealized losses | (539) | (472) | ||
Marketable securities, fair value | $ 40,472 | $ 40,405 |
Cash, cash equivalents and marketable securities (Contract Maturity) (Details) $ in Thousands |
Apr. 30, 2017
USD ($)
|
---|---|
Cost basis | |
One year or less | $ 25,420 |
Over one year and less than five years | 15,359 |
Total | 40,779 |
Fair value | |
One year or less | 25,362 |
Over one year and less than five years | 15,110 |
Total | $ 40,472 |
Cash, cash equivalents and marketable securities (Unrealized Losses) (Details) $ in Thousands |
Apr. 30, 2017
USD ($)
|
---|---|
Less than one year | |
Fair value | $ 25,362 |
Unrealized losses | (207) |
Greater than one year | |
Fair value | 15,110 |
Unrealized losses | $ (332) |
Property and equipment (Schedule of property and equipment) (Details) - USD ($) $ in Thousands |
Apr. 30, 2017 |
Jan. 31, 2017 |
---|---|---|
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 12,728 | $ 11,183 |
Accumulated depreciation | (6,645) | (6,013) |
Property and equipment, net | 6,083 | 5,170 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 1,096 | 860 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 3,643 | 3,129 |
Computer equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 7,989 | $ 7,194 |
Property and equipment (Narrative) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Property, Plant and Equipment [Abstract] | ||
Depreciation expense | $ 632 | $ 447 |
Intangible assets and goodwill (Narrative) (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Capitalized software development costs | $ 2,200,000 | $ 1,900,000 |
Software development costs incurred and expensed | 2,800,000 | 2,100,000 |
Amortization expense | 2,800,000 | 2,500,000 |
Change in goodwill | $ 0 | $ 0 |
Intangible assets and goodwill (Schedule of finite-lived intangible assets) (Details) - USD ($) $ in Thousands |
Apr. 30, 2017 |
Jan. 31, 2017 |
---|---|---|
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 98,441 | $ 95,928 |
Accumulated amortization | (33,758) | (30,908) |
Intangible assets, net | 64,683 | 65,020 |
Capitalized software development costs | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 26,096 | 23,925 |
Software | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 7,383 | 7,041 |
Acquired intangible member assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 64,962 | $ 64,962 |
Commitment and contingencies (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Commitments and Contingencies Disclosure [Abstract] | ||
Lease expense for office space | $ 1,100 | $ 593 |
Expenses for other agreements | $ 120 | $ 60 |
Indebtedness (Details) - Line of Credit - Secured Revolving Credit Facility |
Sep. 30, 2015
USD ($)
|
Apr. 30, 2017
USD ($)
|
---|---|---|
Debt Instrument [Line Items] | ||
Secured revolving credit facility, aggregate principal | $ 100,000,000 | |
Facility term (in years) | 5 years | |
Amounts drawn under Credit Agreement | $ 0 | |
Minimum | ||
Debt Instrument [Line Items] | ||
Commitment fee percentage | 0.20% | |
Minimum interest coverage ratio | 3 | |
Maximum | ||
Debt Instrument [Line Items] | ||
Commitment fee percentage | 0.30% | |
Maximum leverage ratio | 3 | |
London Interbank Offered Rate (LIBOR) | Minimum | ||
Debt Instrument [Line Items] | ||
Variable rate borrowing spread | 1.50% | |
London Interbank Offered Rate (LIBOR) | Maximum | ||
Debt Instrument [Line Items] | ||
Variable rate borrowing spread | 2.00% | |
Customary Base Rate | Minimum | ||
Debt Instrument [Line Items] | ||
Variable rate borrowing spread | 0.50% | |
Customary Base Rate | Maximum | ||
Debt Instrument [Line Items] | ||
Variable rate borrowing spread | 1.00% |
Income taxes (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
Jan. 31, 2017 |
|
Income Tax Disclosure [Abstract] | |||
Income tax provision | $ 1,808 | $ 4,536 | |
Effective tax rate | 11.40% | 36.00% | |
Decrease in effective tax rate from excess tax benefit on stock-based compensation expense | 24.80% | ||
Unrecognized tax benefits | $ 741 | $ 674 | |
Unrecognized tax benefits that would impact the effective tax rate | $ 622 |
Stock-based compensation (Stock-based compensation) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 3,010 | $ 1,822 |
Cost of revenue | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 491 | 375 |
Sales and marketing | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 317 | 213 |
Technology and development | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 672 | 357 |
General and administrative | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 1,530 | $ 877 |
Stock-based compensation (Assumptions) (Details) |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected dividend yield (percentage) | 0.00% | 0.00% |
Expected stock price volatility, minimum (percentage) | 37.90% | 38.29% |
Expected stock price volatility, maximum (percentage) | 38.01% | 38.37% |
Risk-free interest rate, minimum (percentage) | 1.90% | 1.33% |
Risk-free interest rate, maximum (percentage) | 2.07% | 1.52% |
Minimum | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected life of options (in years) | 5 years 2 months 1 day | 5 years 2 months 1 day |
Maximum | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected life of options (in years) | 6 years 3 months | 6 years 3 months |
Stock-based compensation (Narrative) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized stock compensation expense to be recognized in future | $ 23,200 | |
Stock-based compensation expense | $ 3,010 | $ 1,822 |
Stock Options | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average vesting period of non-vested awards expected to vest | 2 years 5 months | |
Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average vesting period of non-vested awards expected to vest | 3 years 4 months | |
Award vesting period | 4 years | |
Stock-based compensation expense | $ 545 | |
Unrecognized stock-based compensation expense related to restricted stock units to be recognized in future | $ 11,600 |
Stock-based compensation (Restricted stock unity activity) (Details) - Restricted Stock Units shares in Thousands |
3 Months Ended |
---|---|
Apr. 30, 2017
$ / shares
shares
| |
RSUs and PRSUs | |
Unvested, beginning balance (shares) | shares | 10 |
Granted (shares) | shares | 326 |
Forfeitures (shares) | shares | 0 |
Unvested, ending balance (shares) | shares | 336 |
Weighted-average grant date fair value | |
Unvested, beginning balance (usd per share) | $ 26.93 |
Granted (usd per share) | 41.61 |
Vested (usd per share) | 46.40 |
Forfeitures (usd per share) | 0.00 |
Unvested, ending balance (usd per share) | $ 41.15 |
Fair value (Details) - Recurring - Mutual funds - USD ($) $ in Thousands |
Apr. 30, 2017 |
Jan. 31, 2017 |
---|---|---|
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | $ 40,472 | $ 40,405 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | 0 | 0 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities: | $ 0 | $ 0 |
Subsequent events (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
May 31, 2017 |
Oct. 31, 2017 |
|
Subsequent event | ||
Subsequent Event [Line Items] | ||
Initial annual lease payments | $ 513 | |
Subsequent event | Minimum | ||
Subsequent Event [Line Items] | ||
Annual lease increase (as a percent) | 2.50% | |
Subsequent event | Maximum | ||
Subsequent Event [Line Items] | ||
Annual lease increase (as a percent) | 3.10% | |
Forecast | Minimum | Definitive asset purchase agreement with BenefitGuard LLC | ||
Subsequent Event [Line Items] | ||
Estimated purchase price | $ 1,500 | |
Forecast | Maximum | Definitive asset purchase agreement with BenefitGuard LLC | ||
Subsequent Event [Line Items] | ||
Estimated purchase price | $ 3,000 |
3_%LDV/55@NSA-CM1F
MU'&2-]YU8.^S^"9_X?.T?^.V$]J1B_'XLK'_K3$>,)7D!D>HQP^V&A):'X[O
M\6SG,9L-;X;E!['U&U=_ %!+ P04 " !2@'B %ZG?]\!.Z[;6GD!9IASYLPP9*.Q+ZX%\.1-2>UR
MVGK?'QAS90M*N"O3@\:;VE@E/)JV8:ZW(*H(4I+QW>Z&*=%I6F31=[)%9@8O
M.PTG2]R@E+"_CB#-F-,]?7<\=TWK@X,562\:^ ;^>W^R:+&%I>H4:-<932S4
M.;W;'XYIB(\!/SH8W>I,0B5G8UZ"\53E=!<$@832!P:!VP7N09TZZ
MI S ]?F=_7.L'6LY"P?W1O[L*M_F]):2"FHQ2/]LQD>8Z[FF9"[^"UQ 8GA0
M@CE*(UU<23DX;]3,@E*4>)OV3L=]G&ZNDQFV#> S@"^ VYB'38FB\@?A19%9
M,Q([];X7X8GW!XZ]*8,SMB+>H7B'WDNQ3WG&+H%HCCE.,7P=LT0P9%]2\*T4
M1_X?G&_#DTV%280G?RE,M@G238(T$J0?EK@5D_Z3A*UZJL V<9H<* "NT\EKL4_@X[=^%K5OMR,5X?-G8_\H8#RAE B<0P[^Y$R*H[!.@VS(5!E1IDF,F5=QF]QR1TUQ_X-+=?J&Z9-.BJK.O1
MT$F-4A9<*IL'5W#GGHK%X-!8OSVXO9X&9C*LZN>W@"P/4OD;4$L#!!0 (
M %*!R$K+<^<[M@$ -(# 9 >&PO=V]R:W-H965T P61$D67'CTF,*
MAQF\2);F)"RS" &PO=V]R:W-H965T !.RG(YG4MX$(5*+D'!7X"\D(LH #I:6K].$#+HYJP44![%#2ZM!0">RR&,VP$?R_&WBNY]M [FRX6&" A!YY.AS.,21J/AK,YBA%8) :;S=$+
M_Q3D-)C/S#^=#&&2YO)K;&WF+Q9SLWBYE,EH"-\NATO:R1AK D^\OXI<53^U
MT^)0E6P;>[:\X-$(%$L"Q7CB+RZ6:I]